Neuregenix successfully completes a long series of studies for AbbVie evaluating the efficacy of novel therapeutic monoclonal antibodies for neurological conditions.
Catalogues & publications
Neuregenix Brochure
Publications
Recent news:
A strong partnership with the College of Medicine and Dentistry – March 19, 2018
UoB publishes the results from a study commissioned to Neuregenix under the 2016 MRC CiC award to Ann Logan where they showed efficacy of an eye drop formulation of anti-VEGF drugs to topically to treat AMD – December 04, 2017
Tikomed signs new collaboration agreements with University of Birmingham and Neuregenix to carry out a pipeline of pre-clinical and clinical trials of ILB for ocular and neurodegenerative conditions. – November 01, 2017
Neuregenix joins the industrial advisory board underpinning the new science for health training program, 2015 – May 06, 2015
Archives
Neuregenix Ltd Copyright 2013